Literature DB >> 9186822

Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat.

R Grilli1, M C Ghigo, A Torsello, M Guidi, M Luoni, V Locatelli, E E Müller.   

Abstract

It is generally accepted that growth hormone influences its own secretion by modulating the activity of GHRH and SRIF neurons. To investigate if GH feedback mechanisms are already operating in the early postnatal life of the rat, we have studied in 10-day-old pups the effects of rhGH and rhIGF-I administration on GHRH and somatostatin mRNA levels. The same experiment was also performed in pups passively immunized with an anti-GHRH antiserum from the day of birth. The latter animal model had been previously characterized for presenting reduced levels of circulating GH and IGF-I. In control pups, neither rhGH (250 micrograms/kg, b.i.d., sc) nor rhIGF-I (150 micrograms/kg, b.i.d., sc) administration induced significant changes of GHRH and SRIF gene expression. The passive immunization against GHRH induced per se a trend toward an increase and a reduction of GHRH and SRIF mRNA levels, respectively. Also in these rats the treatment for 3 days with rhGH and rhIGF-I did not further modify the GHRH and SRIF mRNA levels. Based on these results, we conclude that in the 10-day-old rat GH feedback mechanisms are poorly operative, though a direct ultra-short loop mechanism involving the GHRH and SRIF systems seems already operating.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186822     DOI: 10.1007/BF03346894

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

Review 1.  Growth hormone receptors--their structure, location and role.

Authors:  M J Waters; R T Barnard; P E Lobie; L Lim; G Hamlin; S A Spencer; R G Hammonds; D W Leung; W I Wood
Journal:  Acta Paediatr Scand Suppl       Date:  1990

2.  The development of the hypothalamo-pituitary axis in the neonatal rat: hypothalamic somatostatin and pituitary and serum growth hormone concentrations.

Authors:  P Walker; J H Dussault; G Alvarado-Urbina; A Dupont
Journal:  Endocrinology       Date:  1977-09       Impact factor: 4.736

Review 3.  Neural control of somatotropic function.

Authors:  E E Müller
Journal:  Physiol Rev       Date:  1987-07       Impact factor: 37.312

4.  Antibodies to growth hormone-releasing factor inhibit somatic growth.

Authors:  W B Wehrenberg; B Bloch; B J Phillips
Journal:  Endocrinology       Date:  1984-09       Impact factor: 4.736

5.  Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats.

Authors:  H Abe; M E Molitch; J J Van Wyk; L E Underwood
Journal:  Endocrinology       Date:  1983-10       Impact factor: 4.736

6.  Development of hypothalamic control of growth hormone secretion in the rat.

Authors:  O Khorram; L R DePalatis; S M McCann
Journal:  Endocrinology       Date:  1983-08       Impact factor: 4.736

7.  Growth hormone (GH) deprivation induced by passive immunization against rat GH-releasing factor delays sexual maturation in the male rat.

Authors:  Y Arsenijevic; W B Wehrenberg; A Conz; A Eshkol; P C Sizonenko; M L Aubert
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

8.  Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain.

Authors:  G S Tannenbaum; H J Guyda; B I Posner
Journal:  Science       Date:  1983-04-01       Impact factor: 47.728

9.  Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats.

Authors:  H P Guler; J Zapf; E Scheiwiller; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Growth hormone (GH) autofeedback action in the neonatal rat: involvement of GH-releasing hormone and somatostatin.

Authors:  S G Cella; V De Gennaro Colonna; V Locatelli; V Moiraghi; S Loche; W B Wehrenberg; E E Müller
Journal:  J Endocrinol       Date:  1990-02       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.